MolNFT v2 · #210250 · protein
8FY1: E3:PROTAC:target ternary complex structure (VCB/753b/BCL-2)
8FY1 · von Hippel-Lindau disease tumor suppressor: “E3:PROTAC:target ternary complex structure (VCB/753b/BCL-2)”. X-ray diffraction at 2.56, 1 ligand (YF8), 5 pockets (best druggability 0.68). MolNFT v2 #210250 on GenesisL1: 3D structure…

- PDB
- 8FY1
- Type
- protein
- Length
- 484 residues
- Chains
- 4
- Method
- x-ray diffraction
- Authors
- Nayak, D., Lv, D., Yuan, Y., Zhang, P., Hu, W., Lv, Z., Sung, P., Hromas, R., Zheng, G., Zhou, D., Olsen, S.K.
- Deposited
- 01/25/23
- Collection
- MolNFT v2 / PDB Bank
- Contract
- 0xd58B01f6C18086e5202cdC5D7Ad3E41790360102
- Owner
- 0xF4e1AA6f26B7DA48EeAD9B24a97927303eeA07b8
- Resolution
- 2.56
- Source
- Homo sapiens
- Molecule
- von Hippel-Lindau disease tumor suppressor; Elongin-B; Elongin-C; Apoptosis regulator…
- UniProt
- P40337, Q15370, Q15369, P10415
- Ligands
- YF8
- Pockets
- 5 · best druggability 0.68
Structure
x-ray diffraction · resolution 2.56 · 4 distinct chains · 42% helix, 19% strand (DSSP).
| Chain | Molecule | Type | Residues | Secondary structure | UniProt |
|---|---|---|---|---|---|
| A | von Hippel-Lindau disease tumor suppressor | protein | 144 | 24% helix, 30% strand | P40337 |
| B | Elongin-B | protein | 105 | 21% helix, 32% strand | Q15370 |
| C | Elongin-C | protein | 88 | 48% helix, 15% strand | Q15369 |
| D | Apoptosis regulator Bcl-2 | protein | 147 | 70% helix, 0% strand | P10415 |
Ligands and binding sites
- YF8 · N-[8-(4-{[(1R,3R,4S)-4-(4-chlorophenyl)-1-methyl-3-{[4-(4-{[4-{[(2R)-4-(morpholin-4-yl)-1-(phenylsulfanyl)butan-2-yl]amino}-3-(trifluoromethanesulfonyl)benzene-1-sulfonyl]carbamoyl}phenyl)piperazin-1-yl]methyl}cyclohexyl]methyl}piperazin-1-yl)-8-oxooctanoyl]-3-methyl-L-valyl-(4R)-4-hydroxy-N-{(1S)-1-[4-(4-methyl-1,3-thiazol-5-yl)phenyl]ethyl}-L-prolinamide · ligand · chains A, D
Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.
Pockets
5 pockets found on a 1 Å grid, 1 with a druggability of 0.5 or more.
| Volume (ų) | Druggability | Buriedness | Lining residues | Inside | |
|---|---|---|---|---|---|
| 1 | 550 | 0.68 | 0.78 | 56 | YF8 |
| 2 | 180 | 0.44 | 0.74 | 23 | empty |
| 3 | 62 | 0.31 | 0.74 | 16 | empty |
| 4 | 58 | 0.30 | 0.74 | 11 | empty |
| 5 | 50 | 0.30 | 0.76 | 18 | empty |
Interfaces
4 interfaces between chains.
- B–C · 1142 Ų buried · 15 hydrogen bonds · protein-protein
- A–C · 1068 Ų buried · 12 hydrogen bonds · protein-protein
- A–D · 257 Ų buried · 1 hydrogen bond · protein-protein
- A–B · 191 Ų buried · 1 hydrogen bond · protein-protein
Compared structures
- P40337 · AlphaFold monomer V2.0 prediction for von hippel-lindau disease tumor suppressor (P40337) · a predicted model of the same protein · chain A against A, TM-score 1.00
- Q15370 · AlphaFold monomer V2.0 prediction for elongin-B (Q15370) · a predicted model of the same protein · chain B against A, TM-score 0.99
- Q15369 · AlphaFold monomer V2.0 prediction for elongin-C (Q15369) · a predicted model of the same protein · chain C against A, TM-score 0.98
- P10415 · AlphaFold monomer V2.0 prediction for apoptosis regulator BCL-2 (P10415) · a predicted model of the same protein · chain D against A, TM-score 0.97
Analyse
- Open in the research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides and crosslinks on the 3D structure
- Every structure of UniProt P40337
- Every structure of UniProt Q15370
- Every structure of UniProt Q15369
- Every structure of UniProt P10415
- Elsewhere: RCSB PDB 8FY1 · PDBe 8FY1 · UniProt P40337 · UniProt Q15370 · UniProt Q15369 · UniProt P10415
GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.